Castration-resistant Prostate Cancer
📧 Sign up to get email alerts when something new happens for Castration-resistant Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer [Phase 1]
This is a Phase 1 clinical trial evaluating Pasritamig (JNJ-78278343) in combination with other agents for metastatic prostate cancer, curre…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring [Phase 1]
Phase 1 rollover study by Janssen Research & Development to continue study treatment and ongoing safety monitoring in patients with acute my…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Resistant Prostate Cancer [Phase 1]
Phase 1 study of the androgen receptor antagonist apalutamide in Chinese participants with metastatic castration-resistant prostate cancer; …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating sequencing abemaciclib before 177Lu-PSMA-617 for metastatic castration-resistant prostate cancer, w…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating anti-tumor activity of (177Lu) rhPSMA-10.1 injection in prostate cancer, including metastatic castrati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Castrate Resistant Prostate Cancer Enhertu Therapy [Phase 2]
A Phase 2 clinical trial evaluating Enhertu (trastuzumab deruxtecan) for metastatic castration-resistant prostate cancer is currently recrui…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Denosumab in Combination With Enzalutamide in Progressive Metastatic Castrate-resistant Prostate Cancer and Bone Metastases. [Phase 2]
Phase 2 trial of denosumab in combination with enzalutamide in progressive metastatic castration-resistant prostate cancer with bone metasta…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating a fatty acid synthase inhibitor for castration-resistant prostate cancer is currently recruiting. The sp…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer
This clinical trial update reports on real-world experience with lutetium vipivotide tetraxetan in metastatic castration-resistant prostate …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) [Phase 3]
Phase 3 study evaluating pasritamig versus placebo in late-line metastatic castration-resistant prostate cancer is currently recruiting. Spo…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer [Phase 1, Phase 2]
Clinical trial update indicates Gedatolisib in combination with Darolutamide is being studied in metastatic castration-resistant prostate ca…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the combination of ruxolitinib and enzalutamide for metastatic castration-resistant prostate cancer…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Study of MHB048C in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for MHB048C in patients with metastatic castration-resistant prostate cancer and advanced solid tumors; Phase 1/2, cur…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 1]
A Phase 1 study of ACE-232 for metastatic castration-resistant prostate cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI Versus AAA617 in PSMA Positive First-line mCRPC [Phase 2]
Open-label Phase 2 trial comparing Lutetium-177 vipivotide tetraxetan (AAA617) in combination with an androgen receptor pathway inhibitor ve…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: FPI-2265 (225Ac-PSMA-I&T) and Olaparib for Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) [Phase 2]
Phase 2 clinical trial evaluating the combination of FPI-2265 (225Ac-PSMA-I&T) and Olaparib for metastatic castration-resistant prostate can…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: External Beam and Radioligand Radiotherapy for mCRPC [Phase 2]
Phase 2 clinical trial update describing a study of external beam radiotherapy combined with radioligand radiotherapy for metastatic castrat…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer [Phase 1, Phase 2]
This clinical trial evaluates PDS01ADC in combination with docetaxel and abiraterone for metastatic castration-sensitive and metastatic cast…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer [Phase 1]
Phase 1 clinical trial evaluating adverse events and how ABBV-969 distributes in the body for adults with metastatic castration-resistant pr…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer [Phase 1]
This ClinicalTrials.gov update describes a Phase 1 study of combining Lutetium-177-PSMA-617 with Carboplatin in metastatic castration-resist…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer [Phase 2]
A Phase 2 clinical trial to test Inavolisib for metastatic castration-resistant prostate cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) [Phase 2]
Phase 2 clinical trial of FPI-2265 (225Ac-PSMA-I&T) for PSMA-positive metastatic castration-resistant prostate cancer; the study is currentl…
-
FDA approval · 2026-04-07FDA Approved: PLUVICTO — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for PLUVICTO (lutetium Lu-177 vipivotide tetraxetan) from Novartis, signaling an updated regulatory …
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) [Phase 1]
This is a Phase 1 clinical trial update for AB001, an alpha radioligand therapy, in metastatic castration-resistant prostate cancer; the stu…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial [Phase 2]
The PREDICT trial is a Phase 2 targeted therapy study for metastatic prostate cancer and is currently recruiting.